Clinical Trial Update: Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis

View source ↗

Summary

A clinical trial update presenting classification and characterization of patients treated with efalizumab for plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Raptiva (efalizumab) (efalizumab)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Plaque Psoriasis | Status: TERMINATED